Core Viewpoint - Northrim BanCorp, Inc. reported a mixed financial performance for the fourth quarter of 2025, with a notable earnings miss but continued revenue growth year-over-year [2][3][6]. Financial Performance - The Earnings Per Share (EPS) for the fourth quarter was $0.54, which was below the estimated $0.64, resulting in a 15.63% downside surprise [2][6]. - Revenue for the quarter was $51.66 million, slightly below the anticipated $52.7 million, but it exceeded the Zacks Consensus Estimate by 1.69% and showed a significant increase from $43.87 million in the same quarter last year [3][6]. - Net income for the fourth quarter was $12.4 million, down from $27.1 million in the previous quarter, primarily due to a $14.2 million gain from asset sales in the third quarter [4]. - For the full year ending December 31, 2025, the company achieved a net income of $64.6 million, or $2.87 per diluted share [5]. Financial Ratios - The company has a P/E ratio of 8.82 and a debt-to-equity ratio of 0.09, indicating a conservative financial approach [5]. - The current ratio stands at 0.25, suggesting potential liquidity concerns in meeting short-term obligations [5].

Wall Street expects another strong quarter from Microsoft when the technology behemoth reports earnings next Wednesday. But at least a couple firms are backing off their most optimistic predictions for the stock. ...

Core Viewpoint - McCormick & Company reported disappointing Q4 results, leading to an 8% decline in share price on the day of the announcement, and a nearly 20% loss over the past year [1] Financial Performance - The company's Q4 results did not meet market expectations, resulting in a significant drop in share value [1]

Core Viewpoint - Intel Corporation is a leading technology company in the semiconductor industry, facing competition from AMD and NVIDIA. Despite strong fourth-quarter earnings, the stock experienced a sell-off, prompting Roth Capital to adjust its rating to "Neutral" and raise the price target from $40 to $50 [1][2][5]. Financial Performance - Intel reported strong fourth-quarter earnings that exceeded expectations in both revenue and profit [2]. - The company's stock price was $54.32 at the time of Roth Capital's rating adjustment, with a slight increase of 0.07, or 0.13%, on that day [3][5]. Market Activity - Despite Intel's strong earnings, the stock faced a sell-off while broader market indices, including the Dow, S&P 500, and Nasdaq, saw gains, with the Nasdaq increasing by 0.91% [2]. - The trading volume for Intel's stock was 154.05 million shares, indicating active investor interest [4][5]. Stock Performance - Intel's stock traded within a range of $53.08 to $54.59 on the day, with the highest price over the past year being $54.59 and the lowest at $17.67, reflecting significant volatility [3][4]. - The company's market capitalization is approximately $259.1 billion, underscoring its substantial presence in the tech industry [4][5].

Core Insights - Eastern Bankshares, Inc. (EBC) reported a revenue of $283.5 million for the quarter ended December 2025, marking a year-over-year increase of 25.6% and an EPS of $0.44 compared to $0.34 a year ago, indicating strong financial performance [1] - The revenue exceeded the Zacks Consensus Estimate of $282.41 million by 0.39%, while the EPS surpassed the consensus estimate of $0.41 by 7.32% [1] Financial Performance Metrics - The efficiency ratio (GAAP) was reported at 66.8%, higher than the average estimate of 59.2% based on three analysts [4] - The net interest margin stood at 3.6%, slightly above the average estimate of 3.5% from three analysts [4] - Total interest-earning assets averaged $26.74 billion, below the two-analyst average estimate of $27.39 billion [4] - Net interest income was $237.4 million, exceeding the average estimate of $235.79 million from three analysts [4] - Total noninterest income reached $46.1 million, surpassing the average estimate of $45.92 million from three analysts [4] - Service charges on deposit accounts were $9.9 million, below the average estimate of $12.99 million from two analysts [4] - Other income was reported at -$0.7 million, significantly lower than the average estimate of $5.03 million from two analysts [4] - Interest rate swap income was $1.4 million, exceeding the average estimate of $0.92 million from two analysts [4] - Card income reached $5.9 million, above the average estimate of $4.82 million from two analysts [4] - Investment advisory fees were reported at $18.6 million, slightly above the average estimate of $18.02 million from two analysts [4] Stock Performance - Shares of Eastern Bankshares have returned +8% over the past month, outperforming the Zacks S&P 500 composite's +0.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Byline Bancorp reported revenue of $117.01 million for the quarter ended December 2025, reflecting an 11.8% increase year-over-year and a surprise of +5.13% over the Zacks Consensus Estimate of $111.3 million [1] - The earnings per share (EPS) for the quarter was $0.76, up from $0.69 in the same quarter last year, with an EPS surprise of +6.04% compared to the consensus estimate of $0.72 [1] Financial Performance Metrics - Efficiency Ratio was reported at 50.3%, better than the estimated 52.5% by three analysts [4] - Net Interest Margin stood at 4.4%, exceeding the average estimate of 4.2% from three analysts [4] - Average Balance of Total interest-earning assets was $9.23 billion, slightly below the two-analyst average estimate of $9.39 billion [4] - Net charge-offs of loans and leases were at 0.4%, matching the two-analyst average estimate [4] - Net Interest Income was reported at $101.26 million, surpassing the three-analyst average estimate of $99.04 million [4] - Net gains on sales of loans reached $5.39 million, significantly higher than the three-analyst average estimate of $3.83 million [4] - Total Non-Interest Income was $15.75 million, exceeding the three-analyst average estimate of $13.82 million [4] - Fees and service charges on deposits were reported at $2.8 million, slightly below the estimated $2.82 million by two analysts [4] - Wealth management and trust income was $1.32 million, below the two-analyst average estimate of $1.39 million [4] - ATM and interchange fees were reported at $0.98 million, lower than the estimated $1.1 million by two analysts [4] Stock Performance - Byline Bancorp shares have returned +5.9% over the past month, outperforming the Zacks S&P 500 composite's +0.7% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Insights - USCB Financial Holdings, Inc. reported revenue of $25.53 million for the quarter ended December 2025, marking an 11% year-over-year increase, while EPS rose to $0.44 from $0.34 a year ago [1] - The reported revenue fell short of the Zacks Consensus Estimate of $26.11 million, resulting in a surprise of -2.24%, and the EPS also missed the consensus estimate of $0.51 by -13.73% [1] Financial Performance Metrics - The efficiency ratio was reported at 79.2%, significantly higher than the estimated average of 49.6% by three analysts [4] - The net interest margin stood at 3.3%, aligning with the average estimate based on three analysts [4] - Average interest-earning assets were $2.7 billion, slightly below the average estimate of $2.75 billion from two analysts [4] - Total non-performing loans amounted to $3.14 million, exceeding the average estimate of $1.41 million from two analysts [4] - Net charge-offs to average loans were reported at 0%, compared to the average estimate of 0.1% [4] - Net interest income before provision for loan losses was $22.21 million, slightly below the average estimate of $22.65 million from three analysts [4] - Total non-interest income was $3.32 million, lower than the average estimate of $3.79 million from three analysts [4] - Gain on sale of loans held for sale, net, was $0.2 million, slightly above the estimated average of $0.18 million from two analysts [4] Stock Performance - USCB Financial shares have returned +7.1% over the past month, outperforming the Zacks S&P 500 composite, which changed by +0.7% [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating potential for outperformance in the near term [3]

Core Insights - Intel reported $13.67 billion in revenue for Q4 2025, a year-over-year decline of 4.1%, with an EPS of $0.15, up from $0.13 a year ago, indicating a positive EPS surprise of +86.1% compared to the consensus estimate of $0.08 [1] Revenue Performance - Total net revenues for Intel Products Group were $12.93 billion, slightly above the estimated $12.68 billion, but reflecting a year-over-year decline of 0.7% [4] - Data Center and AI revenues reached $4.74 billion, exceeding the average estimate of $4.36 billion, with a significant year-over-year increase of +39.9% [4] - Client Computing Group revenues were reported at $8.19 billion, slightly below the estimate of $8.33 billion, showing a modest year-over-year growth of +2.2% [4] - Intel Foundry Services generated $4.51 billion, surpassing the estimate of $4.39 billion, with a year-over-year change of +0.1% [4] - Net revenues from intersegment eliminations were reported at -$4.34 billion, better than the estimate of -$4.44 billion, with a year-over-year change of +0.6% [4] Stock Performance - Intel's shares have returned +50% over the past month, significantly outperforming the Zacks S&P 500 composite, which saw a change of +0.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Viewpoint - Abbott Laboratories' shares fell over 9% intra-day following fourth-quarter earnings that met expectations but missed revenue targets, along with weaker guidance for the first quarter [1] Financial Performance - Adjusted earnings per share for the quarter were $1.50, aligning with analyst estimates [2] - Revenue totaled $11.46 billion, below the consensus forecast of $11.8 billion, with total sales increasing by 4.4% on a reported basis and 3.0% organically [2] - Organic growth, excluding COVID-19 testing-related sales, was 3.8% compared to the prior-year quarter [2] Segment Performance - The Medical Devices segment showed strong results, with revenue increasing by 12.3% to $5.68 billion [3] - Diabetes Care sales, including continuous glucose monitoring products, rose by 14.5% to $2.13 billion [3] - Nutrition revenue declined by 8.9% to $1.94 billion due to lower volumes and strategic pricing actions [3] - Diagnostics revenue fell by 2.5% to $2.46 billion, attributed to reduced demand for COVID-19 testing [3] Future Guidance - For the first quarter of 2026, Abbott projected adjusted earnings per share of $1.12 to $1.18, below the analyst consensus of $1.20 [2] - For the full year 2026, Abbott forecasted organic sales growth of 6.5% to 7.5% and adjusted earnings per share of $5.55 to $5.80, exceeding the analyst consensus of $5.17 and representing approximately 10% growth at the midpoint [4]

Core Insights - Procter & Gamble Company (PG) reported second-quarter fiscal 2026 results with earnings per share (EPS) exceeding estimates and year-over-year sales growth driven by improved pricing and a favorable mix [1][2] Financial Performance - The company achieved net sales of $22.21 billion, reflecting a 1% increase year over year, although it fell short of the Zacks Consensus Estimate of $22.29 billion [2] - Organic sales remained flat year over year, with a 1% increase from pricing offset by a 1% drop in volumes [2][4] - Core EPS was reported at $1.88, flat compared to the previous year but slightly above the Zacks Consensus Estimate [1] Segment Performance - Sales growth was led by a 5% increase in both Beauty and Health Care segments, a 1% increase in Fabric & Home Care, and a 2% increase in Grooming, while Baby, Feminine & Family Care saw a 3% decline [4] - Organic sales rose 4% for Beauty, 3% for Health Care, and remained flat for Grooming and Fabric & Home Care, with a 4% decline for Baby, Feminine & Family Care [4] Margin Analysis - Core gross margin declined by 50 basis points year over year to 51.9%, while reported gross margin fell by 120 basis points [6] - Core operating margin decreased by 70 basis points to 25.5%, primarily due to adverse currency effects [7] Cash Flow and Shareholder Returns - The company ended the quarter with cash and cash equivalents of $10.8 billion and generated an operating cash flow of $5 billion [9] - Procter & Gamble returned $4.8 billion to shareholders, including $2.5 billion in dividends and $2.3 billion in share buybacks [10] Fiscal 2026 Guidance - The company reiterated its fiscal 2026 guidance, expecting organic sales growth and core EPS growth between flat to 4% [11] - Revised net EPS growth outlook is now between 1-6%, down from the previous 3-9% range, reflecting increased non-core restructuring charges [12] - Anticipated commodity costs are expected to be neutral, with foreign exchange providing a tailwind of approximately $200 million after tax [13]